Page last updated: 2024-08-21

plumbagin and Fatty Liver, Nonalcoholic

plumbagin has been researched along with Fatty Liver, Nonalcoholic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gaur, IS; Gursahani, MS; Juvekar, AR; Mestry, SN; Munshi, RP; Pai, SA; Panchal, FH	1

Other Studies

1 other study(ies) available for plumbagin and Fatty Liver, Nonalcoholic

Article	Year
Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 111 Topics: Adjuvants, Immunologic; Animals; Antioxidants; Fructose; Inflammation; Lipid Metabolism; Male; Naphthoquinones; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Random Allocation; Rats; Rats, Wistar	2019

Article

Year

Plumbagin reduces obesity and nonalcoholic fatty liver disease induced by fructose in rats through regulation of lipid metabolism, inflammation and oxidative stress.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 111

Topics: Adjuvants, Immunologic; Animals; Antioxidants; Fructose; Inflammation; Lipid Metabolism; Male; Naphthoquinones; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Random Allocation; Rats; Rats, Wistar

2019